Implementation of high-temperature superficially porous technologies for rapid LC-MS/MS diastereomer bioanalysis

Bioanalysis

Volumn 3, Issue 7, 2011, Pages 735-743

  Cunliffe, Jennifer M ^a   Shen, Jim X ^a   Wei, Xianrong ^a   Dreyer, Daniel P ^a   Hayes, Roger N ^b   Clement, Robert P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Cetero Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SCH 900518W; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BIOANALYSIS; BIOTECHNOLOGY; CONTROLLED STUDY; DIASTEREOISOMER; DRUG STRUCTURE; HIGH TEMPERATURE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA; PRECIPITATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS;

BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; HUMANS; LYSOPHOSPHATIDYLCHOLINES; PHOSPHATIDYLCHOLINES; STEREOISOMERISM; SULFONES; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 79953668021     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.17     Document Type: Article

References (31)

1. Pieters S, Dejaegher B, Vander Heyden Y. Emerging analytical separation techniques with high throughput potential for pharmaceutical ana lysis, part I: stationary phase and instrumental developments in LC. Comb. Chem. High Throughput Screen 13(6), 510-29 (2010).
2. Jemal M, Xia YQ. LC-MS Development strategies for quantitative bioana lysis. Curr. Drug Metab. 7(5), 491-502 (2006).
3. Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-throughput quantitative bioana lysis by LC-MS/MS. J. Pharm. Biomed. Anal. 44(2), 342-55 (2007). (Pubitemid 46880094)
4. Churchwell MI, Twaddle NC, Meeker LR, Doerge DR. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825(2), 134-143 (2005). (Pubitemid 41423596)
5. Nguyen DT, Guillarme D, Heinisch S et al. High-throughput liquid chromatography with sub-2 microm particles at high pressure and high temperature. J. Chromatogr. A 1167(1), 76-84 (2007). (Pubitemid 47374710)
6. Shen JX, Wang H, Tadros S, Hayes RN. Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25 pg/ml. J. Pharm. Biomed. Anal. 40(3), 689-706 (2006). (Pubitemid 43227393)
7. Song W, Pabbisetty D, Groeber EA, Steenwyk RC, Fast DM. Comparison of fused-core and conventional particle size columns by LC-MS/MS and UV: application to pharmacokinetic study. J. Pharm. Biomed. Anal. 50(3), 491-500 (2009).
8. Cunliffe JM, Maloney TD. Fused-core particle technology as an alternative to sub-2-microm particles to achieve high separation effciency with low backpressure. J. Sep. Sci. 30(18), 3104-3109 (2007).
9. Badman ER, Beardsley RL, Liang Z, Bansal S. Accelerating high quality bioanalytical LC-MS/MS assays using fused-core columns. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(25), 2307-2313 (2010).
10. Cunliffe JM, Noren CF, Hayes RN, Clement RP, Shen JX. A high-throughput LC-MS/MS method for the quantitation of posaconazole in human plasma: implementing fused core silica liquid chromatography. J. Pharm. Biomed. Anal. 50(1), 46-52 (2009).
11. Hsieh Y, Duncan CJ, Brisson JM. Fused-core silica column high-performance liquid chromatography/tandem mass spectrometric determination of rimonabant in mouse plasma. Anal. Chem. 79(15), 5668-5673 (2007). (Pubitemid 47229813)
12. Dolan JW. Temperature selectivity in reversed-phase high performance liquid chromatography. J. Chromatogr. A 965(1-2), 195-205 (2002). (Pubitemid 34876318)
13. McNeff CV, Yan B, Stoll DR, Henry RA. Practice and theory of high-temperature liquid chromatography. J. Sep. Sci. 30(11), 1672-1685 (2007). (Pubitemid 47180274)
14. Heinisch S, Rocca JL. Sense and nonsense of high-temperature liquid chromatography. J. Chromatogr. A 1216(4), 642-658 (2009).
15. Zhu C, Goodall DM, Wren SAC Elevated Temperature HPLC: principles and applications to small molecules and biomolecules. LCGC Asia Pacifc 8(1), 48-59 (2005).
16. Antia FD, Horvath C HPLC at elevated temperatures: examination of conditions for the rapid sepeatation of large molecules. J. Chromatogr. 4351-4315 (1988).
17. Plumb R, Mazzeo JR, Grumbach ES et al. The application of small porous particles, high temperatures and high pressures to generate very high resolution LC and LC/MS separations. J. Sep. Sci. 30(8), 1158-1166 (2007). (Pubitemid 46895310)
18. Shen JX, Merka EA, Dreyer DP, Clement RP, Hayes RN. Stereoselective quantitation of a serine protease inhibitor using LC-MS/MS at elevated column temperature. J. Sep. Sci. 31(2), 242-254 (2008). (Pubitemid 351279398)
19. Cunliffe JM, Dreyer DP, Hayes RN, Clement RP, Shen JX. Using temperature to optimize resolution and reduce ana lysis times for bioanalytical diastereomer LC-MS/MS separations. J. Pharm. Biomed. Anal. 54(1), 179-185 (2011).
20. Du L, White RL. Reducing glycerophosphocholine lipid matrix interference effects in biological fuid assays by using high-turbulence liquid chromatography. Rapid Commun. Mass Spectrom. 22(21), 3362-3370 (2008).
21. Matuszewski BK. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioana lysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 830(2), 293-300 (2006). (Pubitemid 43075465)
22. Shen JX, Motyka RJ, Roach JP, Hayes RN. Minimization of ion suppression in LC-MS/MS ana lysis through the application of strong cation exchange solid-phase extraction (SCX-SPE). J. Pharm. Biomed. Anal. 37(2), 359-367 (2005). (Pubitemid 40222308)
23. Xia YQ, Jemal M. Phospholipids in liquid chromatography/mass spectrometry bioana lysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun. Mass Spectrom. 23(14), 2125-2138 (2009).
24. Pucci V, Di Palma S, Alferi A, Bonelli F, Monteagudo E. A novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioana lysis by means of HybridSPE. J. Pharm. Biomed. Anal. 50(5), 867-871 (2009).
25. Van Horne KC, Meng M, Marquardt R, Bennett P. Investigation of analyte recoveries from a new sorbent designed to remove phospholipids and reduce associated matrix effects. Presented at: The American Society for Mass Spectrometry, Nashville, TN, May 23-27 2004.
26. Arasappan A, Bennett F, Bogen SL et al. Discovery of Narlaprevir (SCH 900518): a potent, second generation HCV NS3 serine protease inhibitor. ACS Med. Chem. Lett. 1(2), 64-69 (2010).
27. Shackman JG, Watson CJ, Kennedy RT. High-throughput automated post-processing of separation data. J. Chromatogr. A 1040(2), 273-282 (2004). (Pubitemid 38681041)
28. Liu G, Snapp HM, Ji QC, Arnold ME. Strategy of accelerated method development for high-throughput bioanalytical assays using ultra high-performance liquid chromatography coupled with mass spectrometry. Anal. Chem. 81(22), 9225-9232 (2009).
29. US FDA. Guidance for Industry: Bioanalytical Methods Validation, Guidance for Industry: Bioanalytical Methods Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
30. Viswanathan CT, Bansal S, Booth B et al., Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24(10), 1962-1973 (2007). (Pubitemid 47389236)
31. Bansal S, DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J. 9(1), E109-E114 (2007).